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ABSTRACT
This research 1) explores the feasibility of developing a non-invasive probe to precisely
quantify microcirculatory blood flow (tissue perfusion), in real time and in absolute units,
and 2) presents designs and models of such a probe, along with an evaluation of various
design-model combinations.
Bowman et al. have developed an invasive thermodiffusion probe that measures tissue
perfusion accurately, continuously, and in real time. This method employs a self-heated
thermistor placed in perfused tissue. From a knowledge of the power required to heat the
thermistor probe to a given temperature, perfusion can be calculated using an analytical
or numerical model.
Using Bowman's thermodiffusion probe (designed for invasive use) in a non-invasive
manner, a perfusion study was performed. The data clearly show the promise of a non-
invasive thermodiffusion perfusion probe (designed for non-invasive use), and the design
of such a probe was pursued by adapting the invasive technology for a non-invasive
probe. Because perfusion is not actually measured but calculated from measured
quantities by a model of the probe and perfused tissue, the design of the non-invasive
probe occurred hand-in-hand with the development of analytical models.
The results of the clinical study are presented, as well as two designs together with
possible one-dimensional analytical models. Using a finite-difference model of the two
probe designs and the underlying perfused tissue, the errors that result from
approximating these designs as one-dimensional models have been determined. It is
shown that modeling a thin, disk-shaped thermistor probe as a hemisphere of appropriate
radius can result in an error in calculated perfusion which is small enough for clinical use.
Thesis Supervisor: Dr. H. Frederick Bowman
Title: Senior Academic Administrator for the
Harvard/MIT Division of Health Sciences and Technology
Lecturer in Mechanical Engineering, MIT
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1 Introduction
1.1 Motivation
The main function of the circulation is to deliver 02 and nutrients to tissue and
remove CO 2 and other waste products; transport substances, such as hormones, platelets,
and white blood cells to specific sites in the body; distribute water, solutes and heat
throughout the body; and generally maintain homeostasis. Most of these functions
involve delivery or removal of gases or solutes or heat. The major site of this exchange is
the microcirculation. Figure 1.1 shows a diagram of the circulation. The microcirculation
is comprised of arterioles, capillaries, venules, and arteriovenous anastomoses. The blood
flowing through this microcirculatory network is defined as tissue perfusion, or simply
perfusion. Blood flow through larger vessels is spatially focused and directional. In
contrast, tissue perfusion is more of a non-directional, volumetric measure. Perfusion is
discussed more formally in Section 4.1.2.
Although there exist many modalities for quantifying blood flow in larger vessels,
there currently exist no routine, non-invasive methods for quantifying microcirculatory
blood flow (i.e. perfusion) in absolute units in a clinical setting. Given the abundance of
exchange that occurs in the microcirculation, however, it is not surprising that an
accurate, real-time knowledge of microcirculatory flow would be invaluable in many
applications.
1.2 Applications
Potential applications of a non-invasive perfusion probe are many and involve
both research and clinical care. Being non-invasive, the probe would be ideally suited for
routine check-ups or semi-permanent measurements. In addition to the applications for
which the probe must be non-invasive, many of the applications that have in the past
employed an invasive probe would greatly benefit from switching to a non-invasive
probe, thereby reducing the risk of the procedure, patient suffering, expense, and healing
time. Examples of applications of a non-invasive probe include:
0 Assuring graft patency in reconstructive surgery
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* Monitoring ischemia and wound repair in diabetes
* Testing the effect of pharmacological agents on the microcirculation
* Managing shock in a critical care setting
* Investigating vasomotor activity as a potential indicator of cardiovascular status
" Observing the impact of therapy, diet, and life style changes on the
microcirculation
In addition, the thermodiffusion method offers the possibility of determining tissue
thermal properties such as thermal conductivity and diffusivity [1].
1.3 Other Methods
Methods of measuring perfusion currently used in a clinical setting can be roughly
divided into two groups depending on whether the measurement is relative or absolute
[2]. Table 1.1 lists the most common techniques. Relative measurement techniques
include those which measure tissue perfusion directly, but in relative units, and those
techniques which measure another quantity, such as blood flow through large vessels (in
absolute or relative units), from which tissue perfusion (in relative units) can then be
extrapolated. Table 1.1 also divides the measurement modalities into invasive and non-
invasive techniques, showing that there is currently a complete lack of clinical techniques
which measure perfusion non-invasively and in absolute units.
Bowman [3], Valvano [2] and Walsh [4] present a more thorough review of
current and past techniques for measuring tissue perfusion. Webster's book on medical
instrumentation is a good resource for learning about common blood flow measurement
techniques (through large vessels) [5].
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Large Small Arterioles Capillaries VenulesArteries Arteries |
Figure 1.1 The microcirculation in the context of the entire circulation.
Relative Perfusion Absolute Perfusion
Angiography Xenon Washout
Indicator Dilution PET
Invasive Thermal Clearance
Thermodiffusion
Temperature & Color
Blood pressure
Plethysmography
Non-invasive Laser Doppler
MRI
Ultrasound Doppler
Table 1.1 Current methods of measuring perfusion in a clinical setting.
Small Large
Veins Veins
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2 Thermodiffusion Probe
2.1 Basic Operation
The thermodiffusion method is a technique by which tissue perfusion can be
measured. The method works much like a hot-wire anemometer in that perfusion is
determined from the rate at which heat is conducted and convected away from a heated
probe. Bowman et al. have developed an invasive thermodiffusion probe [1, 6]. It
consists of a spherically-shaped self-heatable thermistor probe perched at the end of a
catheter sheath or hypodermic needle, and is meant to be placed in, and completely
surrounded by, perfused tissue (see Figure 2.1).
Measuring perfusion by the thermodiffusion method involves the following steps:
1. A thermistor probe is placed in perfused tissue and the baseline or initial tissue
temperature, Ti, is established (see Figure 2.2).
2. The thermistor probe is self-heated such that its temperature is raised to and
maintained at a fixed value above Ti (see Figure 2.3). The difference between the
volume-averaged probe temperature and T is defined as J Tb. The volume-
averaged temperature of the thermistor probe reaches its steady-state value almost
instantaneously, while the power, q, required to establish and maintain this
temperature is initially very large and then drops off to a steady-state value (see
Figure 2.4). The power applied to heat the thermistor probe in the form of
resistive heating (I 2R) escapes by conduction (q'",nd) through the tissue and by
convection (q',) due to perfusion. The convection of heat due to perfusion is
discussed in more detail in Section 4.1.2.3.
3. From a knowledge of the controlled probe temperature, z Tb; the power required to
maintain it, q; and other, physical parameters of the probe and the surrounding
tissue, perfusion is calculated using an analytical or numerical model.
Rather than presenting the governing equations and solutions for the invasive
method here, I refer the reader to the work by Bowman, Balasubramaniam and Valvano
[1, 6, 7], and instead give a more detailed presentation of the governing equations,
assumptions and solutions for the non-invasive method in Section 4.1.
22
2.2 History of the Development of the Invasive Probe
In a nutshell, the development of the invasive thermodiffusion method consisted
of laying the intellectual foundation for perfusion extraction and then building and testing
prototypes to validate the theory. Once a prototype had been built and the method had
been validated, a commercially marketable device was developed and in-depth animal
and human studies were performed in order to obtain regulatory approval, and efforts are
currently underway to incorporate real-time, absolute perfusion measurement into the
clinical setting (see Table 2.1).
The intellectual foundation of the thermodiffusion method consists of the design
of the sensor, the formulation of the thermal model of this sensor, and the creation of an
algorithm to extract perfusion from the thermal model. The bulk of this work was
performed during the 1970's and early 1980's by H. Frederick Bowman and his graduate
students and colleagues (mainly T.A. Balasubramaniam and J.W. Valvano), first at
Northeastern University in Boston, MA, and then at the Massachusetts Institute of
Technology in Cambridge, MA.
Earlier, in 1968, Chato had proposed inserting a small, heated, spherically shaped
thermistor probe into biological tissues for the measurement of thermal properties. In his
analysis, Chato modeled tissue perfusion as an increase in "effective thermal
conductivity", and the probe as a lumped thermal mass [8].
In the early 1970's, Bowman and Balasubramaniam performed a similar analysis,
but modeled the probe as a distributed thermal mass. For this model, they found open-
form transient solutions to the governing equations for the thermistor probe and the
surrounding tissue, which provided an accurate technique for determining thermal
properties of tissue [7, 9, 10].
Subsequently, Bowman and Balasubramaniam modeled tissue perfusion by the
bioheat equation, an equation proposed in 1948 by Pennes to model the effect of
perfusion on heat transfer in tissue [11]. They found the steady-state solution to this
model for the probe and surrounding tissue, and proposed a method for calculating tissue
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perfusion from a knowledge of the controlled temperature of the probe and the power
required to maintain this temperature [6].
In 1979, Jain published the open-form, transient solution to a set of more
sophisticated governing equations in which he models the thermistor probe as consisting
of an inner, heated core and an outer shell [12]. However, this more complicated model
seems to add little to the overall accuracy of the method, and is therefore not used
subsequently by Bowman.
Valvano greatly contributed to the intellectual foundation by formulating the
closed-form, transient solution for a heated spherical thermistor probe in perfused tissue,
which he published in his Ph.D. thesis in 1981 [2] and in the literature in 1984 [1]. The
key to finding the close-form solution was to express the Laplace transform of the probe
temperature and tissue temperature as a Frobenius series and then perform a term-by-term
inverse transform. He also found that, contrary to what was assumed at the time, the
power vs. time function required to suddenly heat a thermistor probe in perfused tissue to
a fixed temperature is not the same as the function determined by Chato in the 1960's for
a thermistor probe in non-perfused tissue, and Valvano determined the correct function.
In summary, Valvano's work produced an algorithm for extracting perfusion from both
the steady-state and transient models.
On this intellectual foundation, Balasubramaniam, Bowman, Valvano, Woods and
others built and tested many prototypes. Hemedex Inc. was created in Cambridge, MA, to
develop a commercial thermodiffusion device, and animal studies were performed to
validate the thermodiffusion method and refine the device. During the 1990's the use of
the device spread to brain surgery, reconstructive surgery, transplantation, and other
fields of medicine, in the United States and abroad. Martin and Bowman validated the
thermodiffusion probe with the radioactive microsphere technique in 2000 [13].
Regulatory approval was obtained in 2002, and today the Bowman Perfusion Monitor is
the only device on the market capable of measuring perfusion in real time and absolute
units.
A brief history of the perfusion measurement research performed before 1970 by
Von Rein; Hensel, Betz, and Bender; Grayson; and Perl and Hirsch is given by Walsh
[4].
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2.3 History of the Development of the Non-invasive Probe
Various attempts have been made to develop a truly non-invasive sensor that
functions by the thermodiffusion technique, but as far as I know none of the concepts
have had the capability of accurately tracking and quantifying quickly fluctuating
perfusion in absolute units and in real time.
In 1979 Patera and others proposed a very elegant method for determining
perfusion by measuring the phase shift between a sinusoidally applied heat flux at the
tissue surface and the temperature response. This method has the strong advantage of not
depending on the temperature of the probe or the tissue, but only "on frequency, phase
shift, and intrinsic properties of the tissue" [14]. The principal disadvantage of this
method is that the magnitude of the dynamic temperature response, and therefore the
accuracy of the calculated perfusion, decreases with increasing driver frequency. Since
only perfusion fluctuations that are slow compared to the driver frequency can be
measured, this technique cannot track perfusion above approximately 0.1 Hz. If the non-
invasive probe is to be used to investigate vasomotor tone, which includes fluctuations
above 0.1Hz (see section 3.4.1), another method must be used.
In 1984 Walsh showed that a non-invasive probe could be created using two flake
thermistors. Upon analytically modeling the probe as an infinite slab and as a sphere
(both 1-dimensional models), he found that the slab model is inadequate and that the
spherical model is more appropriate. Experimental results showed that the non-invasive
probe is sensitive to changes in perfusion [4].
In 2001 and 2002, I used the invasive probe in a non-invasive manner by placing
the invasive probe on the backhand of approximately 75 subjects, some healthy and some
with heart disease (see Chapter 3). In a nutshell, it was found that while the invasive
probe was able to track perfusion very accurately in some cases, in most cases thermal
communication between the probe and the tissue was too poor to establish or maintain a
sensible signal. In addition, the meaningful signals that were obtained could not be relied
on for absolute values of perfusion. It was therefore concluded that the thermodiffusion
method had great promise for non-invasive use, but that a truly non-invasive probe
should be developed to address the issues of thermal communication and calculation of
perfusion in absolute units.
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Figure 2.1 The thermodiffusion probe produced by Hemedex, Inc. [151.
I I
Figure 2.2 Temperature profile of thermistor probe and tissue before heating.
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Figure 2.3 Temperature profile of the thermistor probe and tissue after heating, at two different
levels of perfusion. k,,,=tissue thermal conductivity, I=current, R=probe resistance.
ATb
qb A
Figure 2.4 Heating the thermistor probe: temperature vs. time and power input vs. time.
Upon heating, AT, reaches a fixed value almost instantaneously. The power required to achieve this
step-change in temperature is initially very large, saturates, and then drops off to a steady-state
value.
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Clinical Studies 1992-present
Regulatory Approval 2002: Approval by the U.S. Food and Drug Administration
Animal Studies 1975-present
2000: Martin and Bowman validate thermodiffusion method against microsphere
technique [13].
2000: Vajkoczy et al. validate invasive thermodiffusion probe in human against Xe CT
Validation Studies [16].1999: Klar et al. validate thermodiffusion probe in pigs against Doppler flowmetry and
H-2 clearance [17].
1984: Valvano and Bowman validate thermodiffusion method in isolated, perfused rat
liver system against multiple radioactive microspheres [18].
Device Development 2000-present Hemedex
1970-1999: Prototype evolution (12 generations).
Prototype 1989: Szaijda develops analog subsystem, data acquisition system [19, 20].1984: Valvano et al. measure thermal conductivity, thermal diffusivity, and perfusion in
small volumes of tissue [1].
Reduction Algorithm 1981: Valvano extracts perfusion from transient and steady-state models [2].1977: Bowman and Balasubramaniam extract perfusion from steady-state model [6].
1981: Valvano solves transient equations for distributed thermistor probe in perfused
tissue (closed form) [2].
1980: Bowman identifies thermally significant vessels [21].
1979: Jain solves transient equations for two-zone distributed thermistor probe in
perfused tissue (open form) [12].
Sensor Design & 1977: Bowman, Balasubramaniam, and Woods solve steady-state solutions for
Thermal Modeling distributed thermistor probe in perfused tissue [6].
1977: Balasubramaniam and Bowman propose method for measuring thermal properties
of biomaterials [7].
1974: Balasubramaniam and Bowman solve transient equations for distributed thermistor
probe in unperfused tissue [9].
1968: Chato solves transient equations for lumped thermistor probe in perfused tissue [8].
Table 2.1 The development of the invasive thermodiffusion probe from the 1960's until present.
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3 Clinical Study: Using the Invasive Probe in a Non-
invasive Manner
3.1 Introduction
3.1.1 Cardiovascular Disease and Atherosclerosis
As of 1998, cardiovascular disease had been the number one cause of death in the
USA since 1918. It accounted for 45% of all deaths, claiming more lives than the next
seven leading killers combined. The underlying problem in cardiovascular disease is
atherosclerosis {Study, 1998 #25}.
Atherosclerosis is the formation of fibrofatty plaques in the vascular lumen,
resulting in calcification and weakening of the vessel wall. Photos of a normal coronary
artery as well as one with build-up of atherosclerotic plaque can be found in [23].
Complications of atherosclerosis include hemorrhage, plaque rupture, and thrombosis.
Common clinical manifestations include heart attack, stroke and aneurysm [24]. The
initiating event in atherosclerosis is endothelial dysfunction [25].
3.1.2 Endothelial Dysfunction
The endothelium is a monolayer of cells that lines the entire vascular system. As a
semi-permeable membrane, the endothelium is critical to vessel wall homeostasis and
blood flow. Its functions are many and include [24]:
- Modulating vascular tone and blood flow
- Maintaining the non-thrombogenic blood-tissue interface
- Metabolizing hormones
- Regulating immune and inflammatory reactions
- Modifying lipoproteins in the vessel wall
- Regulating growth of other cell types, particularly smooth muscle
cells
Endothelial dysfunction, which describes "changes in the functional state of
endothelial cells," is the initiating event in atherosclerosis and plays a role in the disease
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process as well [24]. The endothelium becomes damaged decades before the development
of atherosclerosis and following cardiac events.
3.1.3 Assessment of Endothelial Dysfunction
Many techniques have been developed for evaluating the health of the
endothelium and thereby assessing the onset or progression of atherosclerosis. Anderson
presents a review of the assessment and treatment techniques of endothelium dysfunction
in humans [25]. "Local vascular control depends on a balance between dilators and
constrictors, with endothelium-dependent nitric oxide (NO) being the best characterized
and probably the most important. Nitric oxide is stimulated by a variety of stimuli that
serve as the basis for the assessment of endothelium-dependent vasodilation" [25].
Two vasodilator stimuli used in the assessment of endothelial function are
administration of acetylcholine and flow-mediated vasodilation. The intracoronary
administration of acetylcholine has been the gold standard in testing for endothelial
dysfunction. Acetylcholine triggers the healthy endothelium to release nitric, causing the
blood vessel to vasodilate. In contrast, acetylcholine vasoconstricts the diseased vessel.
Flow-mediated vasodilation (FMD) involves temporary occlusion of a vessel
using a blood pressure cuff. Cuff deflation results in reactive hyperemia, which is a
temporary increase in blood flow beyond the baseline level. Most often, the occluded
artery is the brachial artery, and the technique is called Brachial Artery Reactivity Test
(BART). The magnitude of the reactive hyperemia has been shown to correlate with
coronary endothelial dysfunction [26]. Table 3.1 presents these two techniques
(administration of acetylcholine and FMD).
A variety of sense techniques are available for each of these two methods. Some
are listed in Table 3.2, along with their advantages and disadvantages. It is clear that a
non-invasive, cheap, easy-to-use technique that gives perfusion in real time and absolute
units would be highly desirable. The thermodiffusion method has this potential.
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3.2 Data Gathering
During Summer 2001 and January 2002, I used the invasive thermodiffusion
probe in a non-invasive manner in order to measure tissue perfusion in the backhands of
approximately 80 subjects. The goal of the study was three-fold:
1. Establish a protocol.
2. Determine the feasibility of using the invasive thermodiffusion probe non-
invasively
3. Perform BART on subjects with and without heart disease in order to study the
impact of heart disease on endothelial function and vasomotor activity of
peripheral tissue
3.2.1 Protocol
3.2.1.1 Probe Placement
Location
It makes sense to place the probe on tissue with a high capillary density. This
suggests placing the probe in or close to the digital district as opposed to the forearm.
Informal studies have shown that it is much easier to pick up a sensible signal on the
hand/fingers than on the forearm.
Complete Enclosure
Since the perfusion extraction algorithm assumes a 4n-geometry (spherical probe
completely and symmetrically surrounded by tissue), it is critical that the probe have as
much contact as possible with the surrounding tissue. Most importantly, this will decrease
the likelihood that a slight disturbance in probe position or orientation would disrupt the
measurement.
As shown in Figure 3.1, probes (object shown is not actually the probe) were
placed on the backhand, between the thumb and the index finger, and the thumb and the
index finger were brought together, enclosing the probe (as well as approximately 10-
15mm of wire). The thumb was then taped to the rest of the hand in such a manner that
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the subject could relax his/her hand but the probe would not move. It is important that the
"squeezing pressure" be below the capillary collapse pressure.
"Squeezing Pressure" vs. Capillary Collapse Pressure
It is important that the pressure with which the probe pushes against the tissue not
substantially diminish perfusion, let alone occlude the capillaries. Martin has shown that
a pressure of approximately 5mmHg should not be exceeded [27].
3.2.1.2 Contact Gels
Standard ultrasound gel was used for some of the measurements. It is difficult to
say whether its use improved the measurements. No negative effects were observed.
3.2.1.3 Insulation of the Hand
Wrapping the hand in a towel or blanket insulates it from air currents and
temporary changes in room temperature. Also, it is assumed that the amount of heat lost
along the probe wire is decreased. However, insulating the hand does drive the hand
temperature up.
3.2.1.4 Manual Mode vs. Automatic Mode
The Bowman Perfusion Monitor produced by Hemedex allows for manual or
automatic operation. In automatic operation, the software will recalibrate if limits in
certain parameters have been exceeded. During the occlusion phase of BART, perfusion
drops to zero, and the software will often command a recalibration, frustrating the
measurement (and the measurer). Manual operation sidesteps this problem. However, it is
possible that a recalibration really is necessary, and the measurement in manual mode
would continue despite the need for recalibration.
3.2.1.5 Patient at Rest
Because the probe is not actually completely surrounded by malleable tissue but is
instead in contact with tissue on some areas of its surface and with air/liquid on other
areas, slight perturbation in the probe's position and/or angular orientation can cause
huge, non-physiological spikes or drops in measured perfusion. It is therefore critical than
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the subject's arm, hand and fingers be at complete rest. Interaction with doctors, nurses or
family must be avoided. Even using his/her other hand, e.g. to change the TV channel,
can disturb the measurement.
3.2.1.6 Measurement Duration
Various protocols have been used by different groups. Except for the sense site
and method, the protocol used in this study is representative of many other BART studies
found in the literature.
Ideally, after the calibration period, a 5-minute baseline measurement is recorded.
Subsequently, the cuff is quickly inflated to approximately 50mmHg above systolic blood
pressure (some groups set a safe, fixed pressure for all subjects, e.g. 200mmHg) and left
inflated for 5 minutes, then deflated. After deflation, the measurement should be
continued until perfusion has returned to its baseline value. This typically takes between
5 and 15 minutes. If studies of post-occlusion baseline are planned, the measurement
should be continued for some time after perfusion has returned to baseline values. If pre-
or post-occlusion baseline perfusion is to be analyzed in the frequency domain,
measurement duration and sampling frequency must be chosen such that the desired
bandwidth and resolution are obtained (see section 3.4.5).
3.2.2 Measurement Issues
Many difficulties arose in making perfusion measurements. The most typical
measurement challenges are shown in the middle row of Figure 3.2. They include:
1. Failure to detect physiological baseline perfusion
2. Failure to detect zero perfusion during occlusion despite high occlusion pressure
3. Non-physiological spikes and drops in perfusion
There may exist simple explanations for some of these challenges. For example,
consider the middle row of Figure 3.2. Bowman [28] has suggested that both of these
plots may show normal measurements that are shifted downward or upward due to an
offset caused by a deviation from assumed model conditions (e.g. the 47r-geometry
assumption).
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Perfusion measurements were performed on 80 subjects. A stable baseline
measurement was obtained for approximately 65% of subjects. Of those measurements it
was possible to perform and record BART on 45%, resulting in 21 good BART
measurements (13 of those measurements were recorded from patients with heart disease,
and 8 without heart disease).
Despite this rather low success rate, the measurements clearly prove the feasibility
of a non-invasive thermodiffusion probe. For example, in many cases, the probe was able
to very nicely track drops and rises in perfusion due to BART. Also, as shown in the
bottom row of Figure 3.2, the probe is capable of picking up high- and low-frequency
signals undetectable by most other routine techniques. This frequency information can be
used in analyzing vasomotor activity, as discussed in section 3.4.5. It appears possible
that these capabilities could be harnessed and the difficulties discussed above overcome if
a truly non-invasive thermodiffusion probe were designed and developed-hence the
efforts presented in chapter 4 of this thesis to design a truly non-invasive thermodiffusion
probe.
3.2.3 Non-collocation of Event, Stimulus, and Sense Sites
In this study, the site where
1. the events, such as myocardial infarction and stroke, occur (i.e. the heart),
2. the test stimulus (i.e. occlusion) is administered (i.e. the brachial artery, upper
arm), and
3. the response to the stimulus is sensed using the thermodiffusion method (i.e. the
backhand)
are all non-collocated, as depicted in Figure 3.3. Unfortunately, the three-way
relationship between these sites is not obvious. Vita and Keaney discuss this issue in
particular in their 2002 editorial [29].
In hindsight it is clear that collocating these sites and/or posing a more tractable
and straightforward research question would have led to more useful data. The usefulness
of this study rests mainly in the evidence that the invasive thermodiffusion probe, even
when applied non-invasively, tracks perfusion and temperature very closely, with a high
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temporal resolution, and in real time, and that the development of a truly non-invasive
probe should be pursued.
3.2.3.1 Event Site to Test Site
The reason why the event and test sites were separated is that "although
assessment of coronary endothelial function is clearly germane for coronary artery
disease events, this methodology is limited by the risk and expense of coronary
angiography and selective intracoronary agonist infusion. As a consequence, there has
been considerable interest in the study of endothelial vasomotor function in more
accessible vascular beds, such as brachial circulation... The relevance of the brachial
circulation to coronary and carotid artery events is not obvious. However, the systemic
nature of many risk factors makes it plausible that they might affect central and
peripheral arteries in a parallel manner. Indeed, studies suggest that endothelial
dysfunction detected noninvasively in the arm correlates with coronary endothelial
dysfunction [26]. Despite these findings, it is well recognized that physiological
mechanisms differ importantly according to vascular bed" [29].
3.2.3.2 Test Site to Sense Site
In many published studies, test and sense sites are collocated. In other words, the
response of the brachial artery to BART is measured in the brachial artery, using methods
such as ultrasound and laser doppler flowmetry. Non-invasive thermodiffusion seems to
work best in tissue with a high capillary density such as the skin of the hand and fingers.
For this reason the test and sense sites were non-collocated. Cuff inflation and
deflation on the upper arm are immediately detectable and traceable in the measurement
of perfusion on the backhand, showing clearly that there exists a strong relationship with
very little time lag. No doubt the signal received at the backhand is a filtered version of
what originates in the upper arm, though the exact filter is unknown.
Also, the non-collocation of test and sense site in flow-mediated vasodilation is not
without precedent [30].
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3.3 Database of Measurement Data and Subject Information
The measurement data and subject information for each patient were compiled in
a database, as outlined below.
3.3.1 Measurement Data
The measurement data, automatically collected by the thermodiffusion monitor,
include (all vs. time):
* probe temperature
" skin temperature (measured by the passive thermistor probe)
" power
" perfusion calculated by the transient model
* perfusion calculated by the steady-state model
as well as six other parameters. Measurements were made at 10 Hz and typically lasted
about 25 minutes, adding up to approximately 15,000 measurements of each of 11
parameters for each of approximately 80 subjects. These data were converted and stored
in matrix format in MATLAB for easy manipulation and analysis.
3.3.2 Subject Information
The following information was recorded for each subject:
* gender
* age
* weight
* current medication
The following yes/no information was recorded for each subject:
* coronary artery disease (any history of coronary intervention automatically
qualified)
" diabetes mellitus
* hyperlipidemia (normally evaluated by looking at prescribed medications)
* hypertension
* smoking
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0 family history of heart disease
3.4 Analysis
3.4.1 Physiological Issues
Blood flow is a complex, dynamic phenomenon in space and time. It is influenced
by numerous factors both locally and systemically. For purposes of this clinical study, the
following understanding is important:
* "THE PRIMARY FUNCTION OF THE CUTANEOUS CIRCULATION IS MAINTENANCE OF A
CONSTANT BODY TEMPERATURE. Consequently, blood flow to the skin fluctuates
widely depending on the need for loss or conservation of body heat" [31]. This
severely complicates the analysis of baseline or steady-state perfusion. Local
perfusion can change suddenly in a step-like manner, making it difficult to
determine a baseline value in the first place, and making it clear that any
comparison between baseline values over time is suspect.
* Cutaneous circulation contains oscillations, and "there are indications that these
oscillations may represent the influence of the heart beat, the respiration, the
intrinsic myogenic activity of vascular smooth muscle, and the neurogenic
activity on the vessel wall, with frequency around 1, 0.3, 0.1, and 0.04 Hz,
respectively... In addition, periodic oscillations with a period of I min (0.0 1Hz)
have been demonstrated..." [32].
3.4.2 Filtering
Like much of biological data, the collected perfusion and temperature data
contained much noise, artifact, and human variability. Therefore, it was necessary to filter
the data prior to statistical analysis. As shown in Figure 3.4, the measurements were first
manually segmented using the following information:
" a record of unusual events during the measurement
" an understanding of normal physiological baseline values and responses
* temperature data (especially useful in establishing occlusion starts and stops)
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* known characteristics of the thermodiffusion device
The data were then analyzed in the frequency domain, where non-physiological
oscillations (presumably stemming from instrument artifacts) were filtered out. In
hindsight, there is some concern that the manual segmentation and filtering could have
subjectively corrupted or biased the data by removing what were thought to be abnormal
(assumed to be artifactual) features.
The perfusion and temperature data were both split into baseline and BART
segments and statistically correlated with whether or not the subject had heart disease.
Perfusion and temperature analysis are each discussed in turn.
3.4.3 Perfusion
In the past, the analysis of BART studies has focused on the way vessel diameter
(and therefore perfusion) reacts to reopening of the artery upon cuff deflation, but useful
information may be gleaned from investigating baseline perfusion as well. The high-
sampling rate and high accuracy of the thermodiffusion method makes baseline
examination feasible.
3.4.3.1 BART
The analysis of flow-mediated vasodilation data has generally been limited to
observing how simple BART characteristics vary between subjects. Typical
characteristics include [33]:
* maximum increase in the post-stimulus vessel diameter as a percentage of
baseline diameter (this is the most commonly used characteristic)
* time from cuff deflation to maximum response
* duration of the vasodilator response
* area under the dilation curve
By the thermodiffusion method, perfusion is measured instead of vessel diameter.
Analogous characteristics can be defined as (see Figure 3.5):
* maximum hyperemic increase in perfusion (Wmax-Wbase) as a percentage of baseline
perfusion:
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100 x Wmax - Wbase
Wbase
" time from cuff deflation to maximum response, At
" duration of the vasodilator response, At 2
" area under the dilation curve, A
The last two characteristics, At 2 and A, require that perfusion return to baseline,
and that the measurement be continued to that point. In many cases, post-maximum
perfusion was non-physiological, or the measurement was terminated pre-maturely for
other reasons. The result was that the final sample size was too small to compare subject
populations on the last two characteristics.
Figure 3.6 shows the change in post-stimulus perfusion and time to maximum
response for healthy and heart-diseased subjects. The bars indicate one standard
deviation.
3.4.3.2 Baseline
As discussed in 3.4.1, comparing baseline perfusion values at different times or
between subjects is highly problematic. However, it is reasonable to suggest that some
aspect of baseline perfusion may be affected by endothelial dysfunction and
atherosclerosis. As seen in Figure 3.2, perfusion can be highly variable over a large
frequency range. In other words, perfusion contains relatively large fluctuations of a
variety of frequencies. Some component of this variation may correlate with endothelial
dysfunction. Because most methods are not suited to long, high-sampling rate perfusion
measurements, no standard procedure for analyzing baseline perfusion exists. One
candidate is to look at how often the perfusion vs. time curve changes from increasing to
decreasing or vice versa, or, alternatively, how often it crosses over an average value.
This is close to, but distinct from, a simple spectral analysis because the magnitude of the
oscillation at a specific frequency bears no weight.
As shown in Figure 3.7, determination of the frequency with which a data set
changes from increasing to decreasing or vice versa is dependent on the frequency range
under consideration. In other words, one can count high-frequency, low-magnitude jitter,
or low-frequency, high-magnitude changes, or anything in-between. Thus it is possible to
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create a continuum of 'frequency at which a data set changes from increasing to
decreasing or vice versa' vs. 'frequency range under examination'.
In practice, one can low-pass or band-pass filter the data set with filters of various
cut-off frequencies, and count the number of times the data set changes from increasing
to decreasing or vice versa. Dividing the number of changes by the time interval of the
data set gives the frequency of change.
Figure 3.8 shows the frequency of change at low frequencies (band-pass filtered
with cut-off frequencies of 0.025 and 0.06 Hz) for healthy and heart-diseased subjects.
The lack of statistically significant differences is typical of the results obtained from this
frequency continuum.
3.4.4 Temperature
Since the main function of the cutaneous circulation is thermal regulation, which
is achieved by orchestrating the flow of perfusion through the complex microcirculatory
network, it is conceivable that some aspect of a subject's temperature vs. time profile,
whether baseline or in BART, might correlate with endothelial dysfunction and
atherosclerosis. However, exactly what aspect would provide such a correlation is
unclear, and it seems probable that such a correlation would be a step removed from a
more direct correlation between endothelial dysfunction and perfusion.
Nevertheless, various characteristics of the temperature vs. time profile were
examined. Following are most of the examined characteristics, divided into BART and
baseline.
3.4.4.1 BART
The slope of the temperature vs. time profile during occlusion, as well as the total
temperature drop during occlusion, were investigated.
3.4.4.2 Baseline
In the time domain, the mean and standard deviation of the temperature vs. time
profile were examined. The signal was also investigated in the frequency domain. Several
profiles showed a very large spike around 2 Hz, which is thought to be an artifact of the
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thermodiffusion device. Also, the "frequency of change" analysis introduced in section
3.4.3.2 was applied to the temperature profile.
Unfortunately, the correlations between these temperature characteristics (in
BART and baseline) and the subject's disease state proved either statistically
insignificant or physiologically meaningless, and are therefore not reproduced in this
thesis.
3.4.5 Frequency-domain Analysis
As stated above, it is reasonable to think that differences might exist in the
frequency spectrum of the perfusion vs. time profile (and possibly of temperature as well)
between subjects with and without endothelial dysfunction. In the past, low sampling
rates and short measurement durations have precluded thorough investigation of the
frequency spectrum. However, some methods, such as the thermodiffusion method, are
capable of providing high sampling rates, and could therefore be used to gather data for
examination in the frequency domain. For example, the data for this study were gathered
at 10 Hz, and the average duration of recorded stable baseline perfusion was
approximately 2 minutes (120 seconds). The highest non-aliased frequency is given by
the Nyquist theorem as 5 Hz, and the lowest frequency is given by the frequency
resolution as 1/120s=0.0083 Hz.
Though no statistically significant correlations were obtained from the data of this
study, it is reasonable to think that frequency domain analysis of perfusion may provide a
valuable view of the differences between subjects with and without endothelial
dysfunction. Kvernmo et al. present some of the promises and challenges associated with
the frequency domain analysis of perfusion [32].
3.4.6 Conclusions
The goal of this study was three-fold: to establish a protocol, to investigate the
feasibility of a non-invasive thermodiffusion probe, and to study correlations between
cutaneous circulation (in baseline and BART) and endothelial dysfunction. Several
conclusions can be drawn:
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3.4.6.1 Feasibility of a Non-invasive Thermodiffusion Probe
" The thermodiffusion method, applied non-invasively, is sometimes capable of
tracking (relative) perfusion very closely.
" The thermodiffusion probe offers advantages over other perfusion measuring
devices, such as high sampling frequency, which could be very useful in analysis.
" However, most of the time, poor thermal communication between the probe and
the skin caused unstable and non-physiological signals. In addition, when stable
signals were obtained, the absolute magnitude had no meaning since the model
assumption of isotropic 47r-geometry was not valid.
" Therefore, the development of a truly non-invasive should be pursued.
3.4.6.2 Cutaneous Circulation and Endothelial Dysfunction
* Although the initial sample population was large, much of the data were non-
physiological and therefore discarded. The resulting final data set was quite small
(only 21 good BART tests).
* BART studies in the literature show a correlation between endothelial dysfunction
and characteristics of vessel diameter vs. time, as discussed in section 3.4.3. The
data in this study were not found to be statistically significant with regard to
analogous perfusion characteristics. This lack of statistically significant results
was likely caused by a combination of two of the major difficulties of this study:
measurement noise caused by poor thermal communication and poor thermal
stability at the probe-tissue interface; and non-collocation of event, stimulus, and
sense sites.
* The non-collocation of event site, test site, and sense site made interpretation of
results difficult.
* With a high sampling rate and the possibility of long-duration measurements, a
reliable non-invasive thermodiffusion method/probe would allow for new analysis
techniques, especially frequency domain analysis of baseline perfusion.
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Figure 3.1 Non-invasive placement of the thermodiffusion probe (originally designed for invasive use)
for non-invasive clinical study (the object shown is not the actual probe).
Stimulus Normal Dysfunction
function
Acetylcholine vasodilation vasoconstriction
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Table 3.1 Two tests for endothelial dysfunction.
Upon intracoronary administration of acetylcholine, the healthy vessel vasodilates while the diseased
vessel vasoconstricts; following temporary occlusion, the healthy brachial artery shows more
pronounced reactive hyperemia compared to the diseased artery.
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Coronary Laser dopplerSense method ag grpyUltrasoundfow er
angiography flowmetry
Vascular bed Coronary circulation Brachial artery Forearm microvasculature
Acetylcholine (by Acetylcholine or Acetylcholine orStimulus intracoronary infusion) temporary occlusion temporary occlusion
(FMD) (FMD)
Measurement . Net erythrocyte velocity
variable Vessel diameter Vessel diameter(dplrsitvariable (doppler shift)
Vasoconstriction vs. Vasoconstriction vs.
Test variable vasodilation vasodilation Perfusion
Change in diameter
Looks at coronary circ. . Minimally/non-invasiveAdvantages (where events occur) Non-ivasive Continuous, real time
Invasive Not in absolute units
Disadvantages Risk, cost of cardiac Ultrasound technician Depends on optical tissuecatheterization Expensive equipment properties
die injection
Table 3.2 Comparison of three of the most popular sense methods used in tests of endothelial
dysfunction.
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Figure 3.2 Challenges and strengths of the thermodiffusion method.
A clear signal is shown in the top row; failure to pick up baseline perfusion and failure to measure
zero perfusion during occlusion are shown in the middle row; the unique ability of the
thermodiffusion method to clearly pick up a large range of frequencies is shown in the bottom row.
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Figure 3.3 Non-collocation of event, test, and sense sites.
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Figure 3.4 Flow chart of segmentation, filtering, and analysis process.
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Figure 3.5 Commonly used metrics in the Brachial Artery Reactivity Test (BART) (top curve is
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4 Theoretical Study: Design and Thermal Modeling of a
Non-invasive Probe
4.1 Governing Equations
As explained in Section 2.1, from a knowledge of the controlled temperature of
the thermistor probe and the steady-state power required to maintain that temperature,
tissue perfusion can be obtained from an analytical or numerical model of the probe and
tissue. Indeed, an analytical or numerical model is necessary to obtain perfusion (unless a
calibration curve of perfusion vs. power is experimentally produced for each probe). This
section explores the analytical models available for modeling the thermistor probe and
the adjacent perfused tissue.
The thermistor probe and adjacent tissue can be thermally modeled in a variety of
ways. In 1985, Eberhart and Shitzer compiled two volumes on various subjects in heat
transfer in medicine and biology, including ten chapters on the thermal modeling of
tissues [34]. The model presented here is discussed in great detail in those chapters, but
originates from Pennes [11] and is essentially the same as the model used by Bowman,
Balasubramaniam, Valvano, Walsh, and others.
As stated in earlier chapters, the thermodiffusion method involves a self-heated
thermistor probe in thermal communication with tissue. The non-invasive
thermodiffusion probe would presumably rest on the tissue surface. In order to maximize
the signal and simplify the analysis, the probe is insulated on all sides except the probe-
tissue interface. Likewise, the tissue surface is assumed insulated everywhere except the
probe-tissue interface.
4.1.1 Thermistor Probe
In this analysis, the thermistor probe is assumed to be uniform in terms of thermal
transport properties and volumetric heat generation. Jain modeled the probe as a two-
zone sphere consisting of an internal core, in which heat is uniformly generated, and an
outer, non-heated layer [12]. However, validation studies of the invasive perfusion device
developed by Bowman et al. show that a simple 1-zone spherical model is sufficient [13].
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The thermistor probe can be modeled by the standard heat diffusion equation:
v2 (kT p i - PbCb a ,
b
where Tb~probe temperature, kb~probe thermal conductivity, q,"'=volumetric heat
generation in the probe (by resistive heating), pb=probe density, cb=probe specific heat,
and t-time. A detailed report on self-heated thermistors is given by Sapoff and
Oppenheim [35].
4.1.2 Tissue
Biological tissue is far more complex and challenging to model than the
thermistor probe. Tissue heterogeneity and microcirculatory heat transport are two of the
main challenges.
4.1.2.1 Microscopic Tissue Heterogeneity
Tissue is terribly heterogeneous, made up of microscopic components such as
cells (-IOpm) and microvasculature (~ 10-150tm). "It is clear that an exact accounting of
these microscopic features, including the effect of blood flow through each vessel, would
be highly impractical. A more tenable approach would be to seek a formulation which
accounts only for the collective behavior of the microscopic features. This is analogous to
the "continuum" formulation of non-biological tissues: ignoring the presence of
molecules, and sometimes crystal grains and grain boundaries" [36].
In order to justify a continuum formulation, it must be shown that the thermally
interrogated volume is large compared to microscopic thermal heterogeneities. First, it is
clear that tissue far removed from the heated probe does not experience an increase in
temperature, i.e. T,(oo)=T for all t, where T, is the tissue temperature, Ti is the initial
tissue temperature (before heating), and t is time. The thermally interrogated volume can
be defined as the volume of tissue within the boundary at which the tissue temperature
has dropped to a certain fraction of the temperature at the tissue-probe interface, all with
reference to the tissue temperature at infinity. In this thesis, this fraction is arbitrarily
taken to be 10%. Thus the interrogated volume is the volume within the boundary at r for
which
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Tm(r) 
- T > 0.1
Tm(interface) 
- T
Using the finite-difference analysis presented later in this chapter it was shown
that for a disk-shaped thermistor probe of radius 1mm and typical thermal properties (see
List of Values), placed on tissue of typical thermal properties and zero perfusion
(perfusion, w, will be formally introduced in Section 4.1.2.3), and heated to ATb=3.30C
(ATb=2.9 0 C for w=20 kg/m3s), the interrogated volume is roughly a hemisphere of radius
3.6mm (2.2mm for w=20 kg/m s). In both cases the probe was heated by 7.5MW/m3 .
Thus, the interrogated volume for average perfusion levels is roughly a hemisphere of
radius 3mm, with volume~50mm and interface area~30mm2
Approximately, 1mm 2 of skin is supplied by 15 capillary loops and 300
anastomoses in fingers/feet (through which 60% of blood passes). Also, 1cm 3 of muscle
tissue contains approximately 400 arterioles and 10'000 capillaries [6].
Thus, roughly speaking, the tissue volume thermally interrogated by a probe of
radius 1mm and typical thermal properties (see List of Values) contains approximately
106 cells, 120 to 750 capillary loops, 3000 to 15,000 anastomoses (in fingers/feet), and, in
the case of muscle tissue, 20 arterioles. Therefore, a continuum formulation is justified,
meaning that thermal transport properties such as thermal conductivity and diffusivity
represent average tissue values.
4.1.2.2 Macroscopic Tissue Heterogeneity
Various tissues display heterogeneities in tissue composition on a macroscopic
scale as well as on a microscopic scale. Human skin is composed of the top, thin (sub-
millimeter) layer, the epidermis, followed by a thicker, perfused layer, the dermis. The
combined thickness of the epidermis and dermis ranges from 1.4mm on the backhand to
3.9mm on the soles of the feet [37]. For a histological stain of the epidermis and dermis
of skin tissue, see [38]. The dermis is perfused by a network of arterioles, capillary
networks, venules, and anastomoses. From a horizontal plexus of arterioles running deep
in the dermis, vessels run upward to a superficial horizontal plexus, which feeds the
capillary loops that climb to the interface of the epidermis and dermis. For a diagram of
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the vasculature of the dermis and epidermis, see [39]. Detailed information on human
skin can be found in [40].
4.1.2.3 Transport of Heat by the Circulatory System
"The detailed description of the local contribution of blood perfusion to energy
exchange is an intricate task. Blood vessels are organized in a nonregular manner in most
tissues. Blood flow rates vary considerably with both time and position. Alternate flow
routes may be opened and closed (collateral circulation) in response to need, on a
dynamic basis" [41].
Chen explains that "there are at least three potential mechanisms for the
microcirculation to contribute to heat transfer. Firstly, the vector average blood velocity
in the microvasculature may have a mean convective contribution, much like that in
nonbiological porous fluids. Secondly, the multidirectional aspect of blood flow in a
tortuous microvascular network may provide a contribution similar to that of random
molecular motion or turbulent eddies, resulting in an effective diffusivity and thus a
conductive contribution. Finally, the microvasculature distributes essentially fresh
(arterial) blood to ever cubic millimeter of tissue. It is natural to expect that there would
be a heat transfer contribution directly proportional to this distributed perfusion term"
[36]. Chen proceeds to formulate the heat transfer contribution of each term, but admits
in the end that such rigorous mathematical formulations are of limited use since, at least
as of the time of publication of Chen's formulation (1985), data on the vascular
architecture were neither detailed enough nor comprehensive enough to determine all the
parameters of the formulation.
Probably the most commonly used approach to modeling the heat transfer
contribution of the microvascular stems from the experimental work of Pennes [11], and
is based on Fick's principle, which can be stated as follows: the time rate at which an
organ or control volume stores a substance is equal to the blood flow rate times the
arterial level of the substance minus the venous level of that substance:
qc = WC1 (Trt - Tren),
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where q',,, =volumetric heat removed by convection due to perfusion, w=perfusion,
CbI-specific heat of blood, Tar,=temperature of arterial blood, and TvenAtemperature of
venous blood.
In this formulation, perfusion is modeled as a volumetric phenomenon-a heat
sink or source, depending on the relative temperature magnitudes of blood its
surroundings. The units of perfusion can be thought of as a mass or volume of blood
flowing through a mass or volume of tissue per unit time. In this thesis, the SI units
kblood are used. Physiologists generally prefer the units of rboo . Assuming
M 3 tssue - s 1 0 0 g,,,,,- mm
that the density of blood and tissue are equal, 1 kg/(m3 s) = 6 ml/(100g*min). Very
roughly, perfusion ranges in the body from about 1 or 2 kg/m3 s to 15 kg/m3 s.
Pennes went on to assume that by the time the blood has passed through the
capillaries and into the venules, the blood has thermally equilibrated with the surrounding
tissue, so that Ten=Tm. Later, Chen and Holmes found that most of the thermal
equilibration actually occurs between the terminal arterial branches and arterioles [36]. It
should be mentioned that some controversy has surrounded Pennes' model of
microcirculatory heat transfer. Nevertheless, the fact that it has been used successfully by
many researchers over the last fifty years justifies its future use.
With Tven =Tm,
q,"', = Wcb (ar, - Tm)
Combining the microcirculatory heat transfer term with the standard heat diffusion
equation, the governing equation of perfused tissue becomes
aTm
v 2 (kT+ q'"+ WCbI (Ta, -Tm) = PmCm a ,M at
where km=tissue thermal conductivity, q' = metabolic heat generation in the tissue,
pm=tissue density, cm=tissue specific heat, and t=time.
4.1.3 Probe-Tissue System
Combining the governing equations for the thermistor probe and perfused tissue,
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aT
v2 (kbT+q"- pbCb aob in probe
v 2 (kmTr)+q"+ WCb(T,~, - T)= Pmc, T in tissuem m at
These partial differential equations are subject to the initial condition of uniform
temperature throughout the thermistor probe and tissue before the probe is heated,
Th =T t<O
T =T t<0
and subject to the boundary conditions of continuity of temperature and flux at the probe-
tissue interface; zero flux at the probe-insulation interface; and zero temperature rise in
the tissue at infinity:
Tb = T at probe - tissue interface
kbVT = kmVTm at probe - tissue interface
kbVT = 0 at center (sphere, cylinder) or insulated back (slab)
T,, = T at infinity
4.1.4 Non-dimensionalized Equations
Patera presents three dimensionless groups which characterize the steady-state
problem for various one-dimensional geometries (e.g. sphere, infinite slab, infinite
cylinder) [42]:
ATbkm
q'"L2
7= WCbIL
km
kb
=km
where O=dimensionless probe temperature, y=dimensionless perfusion, P=dimensionless
thermal conductivity, and L =characteristic length (L=a for the sphere and infinite
cylinder (a is the radius of the spherically-shaped or disk-shaped probe), and L=h for the
infinite slab, where h is the height of the slab).
Plugging these dimensionless variables into the governing equations above,
dimensionless time becomes
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t*att* =-ci
where a=thermal diffusivity.
4.2 Solutions
Sections 4.2 and 4.3 do not discern between invasive and non-invasive geometries. This
distinction is discussed in Section 4.5.
4.2.1 One-dimensional solutions
Steady-state and transient solutions exist for at least three one-dimensional
geometries: the sphere, infinite slab, and infinite cylinder.
A practical way of solving the governing equations is given by Bowman et al. [6]
and involves substituting the following three variables into the governing equations:
Vb Tbjr)-T
vm =Tm(r) 
- T.
M =l ("Twei art -
The steady-state solutions presented in 4.2.1.1 must hold true when the probe is unheated,
in which case T-Tm=-Ti. It follows that
V = 0 or
T, = Tar + '"
WCbl
Thus it is seen that metabolic heat generation establishes the initial or baseline
temperature. This is a fortunate by-product of modeling by the bioheat equation because
knowledge of Tart and q, are no longer needed to solve for the temperature profile.
The thermal contact resistance between the thermistor probe and the skin can be
assumed negligible because high-conductivity materials such as gels could be added at
the interface [43]. In a similar vein, it can easily be shown that if an electrode must be
placed at the interface between thermistor probe and skin (in order to ensure uniform heat
generation in the probe), the temperature drop across the electrode is on the order of 1000
times smaller than ATb and is thus negligible (assuming disk radius of 0.5mm and a
Palladium electrode with thermal conductivity 70W/mK).
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4.2.1.1 Heated Sphere in Infinite, Perfused Tissue
The steady-state solution for a spherically-shaped thermistor probe of radius a
embedded in perfused, infinite tissue can be found by integrating the governing probe
equation. The solution for the tissue can be found by plugging the ansatz
vm(r) = C e(2
r
into the governing tissue equation, where r is the distance from the origin and C and C2
are unknown constants. The solutions are [6]:
v (r)- 2 r 16 kb 3km Wcbl 1
km a
exp WcbI (a - r)
vm "ar)= km,
3 km r Wcbi +
km a
The temperature profiles of probe and tissue are shown in Figure 4.1 for various levels of
perfusion.
Due to symmetry, this solution also holds for a hemispherical probe embedded in
a semi-infinite solid, where the free surfaces of the probe and tissue are insulated.
Open-form and closed-form transient solutions are given by Jain [12] and Valvano [1],
respectively. It must be mentioned that the closed-form transient solution by Valvano was
derived using a term-by-term inverse transform in which terms of negligible contribution
were dropped. It appears that the final solution can be used with accuracy to calculate the
power required to reach and maintain a controlled volume-averaged probe temperature.
However, the solution of probe temperature as a function of space and time is itself not
reliable. As far as I know, there exists no closed-form transient solution of the
temperature distribution in a heated sphere and the surrounding perfused tissue.
4.2.1.2 Heated, Infinite Slab on Semi-Infinite, Perfused Tissue
The steady-state solution for a thermistor probe in the shape of an infinite slab of
height h, insulated on one side and abutting on the other side a semi-infinite, perfused
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tissue, can be found by integration of the governing probe equation. The solution for the
tissue can be found by plugging the ansatz
Vm (z) = Ce C2Z
into the governing tissue equation, where z is the tissue depth, measured from the side of
the slab not in contact with the tissue (i.e. the probe-tissue interface is at z=h), and C1 and
C2 are unknown constants. The solutions are:
V(Z)= (h2z)+U"h 
1
2 kb km Wcbi
km
"h exp Wcb h(h-z)]
km Wchl
km
The temperature profiles of probe and tissue are shown in Figure 4.2 for various levels of
perfusion.
It is very informative to compare the solutions for the sphere and infinite slab.
Many similarities are apparent. However, one critical difference between the sphere and
the slab for both probe and tissue solutions is found in the denominator:
sphere: Wc b +
km a
slab: : b
km
While a solution exists for the sphere for zero perfusion, the solution for the infinite slab
(and for the infinite cylinder) blows up for zero perfusion! This trend can be observed in
Figure 4.2. The geometry of a sphere is able to dissipate heat by conduction alone, while
for the infinite slab (and the infinite cylinder), heat transfer by convection due to tissue
perfusion is very important-to the point of determining the form of the solution (i.e. for
zero perfusion the solution takes on an entirely different form).
Transient solutions of the governing equations for the slab-shaped thermistor
probe and adjacent tissue are given by Walsh [4]. However, accuracy is suspect [44].
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4.2.1.3 Heated, Infinite Cylinder in Infinite, Perfused Tissue
The solution for a thermistor probe in the shape of an infinite cylinder, placed in
infinite, perfused tissue involves modified Bessel functions, and is given by Patera [42].
Patera also looked at the effect of probe geometry on the accuracy of tissue perfusion
calculations, and compared the sphere vs. infinite and finite cylinders (see Section 4.3).
4.2.2 Higher-dimensional Solutions
As far as I know, no n-dimensional closed-form solutions are available for n>2,
be they steady-state or transient. One of the closest available solutions is given by
Carslaw and Jaeger for the temperature profile in semi-infinite, unperfused tissue heated
with uniform flux over a circular region on its surface [45].
4.3 Error Analysis
Patera presents an error analysis of perfusion vs. measured quantities (such as
temperature, characteristic probe length, power, specific heat of blood, and thermal
conductivity of tissue) for spherically and cylindrically shaped probes [42]. He shows
that a cylindrically shaped probe is superior to a spherically shaped probe because
perfusion is far less sensitive to errors in the measured quantities for the cylinder than for
the sphere. The goal of this present section is to extend Patera's work to thermistor
probes in the shape of an infinite slab. Infinite slabs are obviously impractical, but
provide helpful benchmark values for the designs presented in 4.5.
Following Patera's derivation, the sensitivity rq of a parameter y on the
measurement of parameter x is given by
ay
7y -Y=xaty
ax y ax'
x
According to Patera, "Given the accuracy ax/x to which x can be found, a change
in the measurement system which decreases the 1,my will result in a more accurate
determination of y" [42]. Patera determined that, for the sphere and the infinite cylinder,
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77ATb,w = NV
lq,w =N
7lCbl,W =1
7k,,,w=1 N
G7a,w = 21-N
where
N(y)= 7 2
a 0
0 ay
and y and 0 are introduced in 4.1.4. I have shown that this derivation is true for the
infinite slab as well. Evaluating N for the sphere and infinite slab,
Nsphere=2 +1i
N slab()=2 +1
3 p
where (p is likewise introduced in Section 4.1.4.
Figure 4.3 shows the sensitivity of w on the measurement of ZlTb, 7T,,w, for a
sphere, an infinite cylinder, and an infinite slab (the data for the infinite cylinder are
taken from Patera [42]). As noted previously by Patera, w is far less sensititive on errors
in ATb for an infinite cylinder than for the sphere. Here I have expanded Patera's work to
include the sensitivity for an infinite slab. As shown, w is even less sensitive for an
infinite slab than for an infinite cylinder. A two-dimensional, non-invasive probe will
presumably have a sensitivity of w on ATb that is intermediate between that of a sphere
and an infinite slab. In other words, the non-invasive probe represents an improvement
over the spherically-shaped invasive probe in terms of error sensitivity.
It is informative to take a look at the sensitivity of w on other measured quantities
as shown in Figure 4.4. In particular, note that w is most sensitive to errors in the
measured value of the slab height, h.
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4.4 Simultaneous Selection of Designs and Models
As explained in Section 2.1, from a knowledge of the controlled temperature of
the thermistor probe and the steady-state power required to maintain that temperature,
tissue perfusion can be obtained from an analytical or numerical model of the probe and
tissue. Indeed, an analytical or numerical model is necessary to obtain perfusion unless a
calibration curve of perfusion vs. power is experimentally established for each probe.
Therefore, it is critical to design the thermistor probe hand-in-hand with analytical and/or
numerical modeling to ensure that an accurate model of the design is available for
perfusion extraction.
4.5 Design-Model Combinations
The two most promising designs are shown in Figure 4.5.
4.5.1 Disk Design
4.5.1.1 Description
The first design is a simple disk of radius a and height h resting on tissue. The
exposed surfaces of the probe and tissue are insulated. This design is called "Disk".
4.5.1.2 Dimensions
The dimensions of the disk are constrained by a variety of limits:
* Typical thermistors such as those fabricated by Thermometrics have dimensions
between 0.5mm and 2mm in diameter/width.
" The (presumably flat) thermistor probe must lie flush against the tissue surface to
ensure good thermal communication. Anatomical topography constrains the disk
diameter to less than approximately 10mm.
* It is important to keep the thermal mass of the probe as low as possible in order to
ensure good dynamic tracking. Low thermal mass necessitates a small value of h,
perhaps on the order of 0.5mm.
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No doubt, a non-dimensional analysis would be helpful in evaluating designs of various
dimensions. However, its usefulness is limited by the fact that the range of allowable
dimensions is quite small.
4.5.2 Disk and Ring Design
4.5.2.1 Description
The second design was suggested by Mikic and represents an effort to
approximate the one-dimensional temperature distribution in an infinite slab in order to
facilitate analytical modeling [43]. It consists of an inner disk of radius a, and an outer
ring of outer radius a,,,, both of height h. The disk and ring are both heated, though not
necessarily by the same amount. A thin insulating ring separates the disk and ring in
order to prevent heat transfer from the inside to the outside. It is the disk (not the ring) for
which the temperature is controlled, and the power required to maintain this temperature
is used in the calculation of perfusion. This design is called "Disk and Ring."
4.5.2.2 Dimensions
Although the size constraints for the Disk design apply to the overall body of the
Disk and Ring design as well, the situation is complicated by extra choices such as the
ratio of aou, to ain. One criterion for determining these extra variables is that the heat
transfer from the inner disk to the tissue resemble as closely as possible the heat transfer
from an infinite slab to tissue. Adiabats show the direction of heat flow. Considering that
the adiabats in tissue under an infinite slab are straight lines, the straightness of the
adiabats in tissue under a disk can be used as a measure of how well a disk resembles an
infinite slab (with regard to heat transfer, of course).
Using a coarse version of the finite-difference model (FDM) described below, the
heat transfer from the disk was simulated numerically, and the deviation, 5, of the adiabat
from a straight line (at a given tissue depth) was determined for various probe dimensions
and heat fluxes.
The following trends were observed:
1. Increasing the ratio ao,,/aj, decreases 5(see Figure 4.6). This makes sense since
the infinite slab, for which c=O, has a ratio aout/ain of infinity.
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2. Increasing the ratio q0,,/qi decreases 1, mainly by strongly reducing 5 at small
tissue depths.
3. Increasing qu, and qj, simultaneously has negligible effect on .
4. Varying perfusion has negligible effect on .
5. Increasing h has negligible effect on 3.
Thus the disk and ring should be designed to maximize the ratio a 0,1/aj,, possibly with
qout>qin (though qourqn may introduce considerable complexity).
4.5.3 Models
As stated above, no solutions exist for the two-dimensional temperature profiles
that would exist for the two designs suggested above. The main contribution of this thesis
is the examination of whether the two-dimensional designs could possibly be
approximated by one-dimensional models, and what the ensuing errors in calculated
perfusion would be. It is immediately evident that both the Disk design and the Disk and
Ring design could possibly be modeled by a (one-dimensional) infinite slab. It is also
possible to approximate the Disk design by another 1-dimensional model: when one
considers that, due to symmetry, the solution of the sphere in infinite tissue is identical to
the solution of a hemisphere in a semi-infinite tissue (with all exposed surfaces
insulated), and that the isotherms in tissue heated by a disk approach at a large distance
those of the hemispherical solution (which are perfectly spherical), one might suspect that
the Disk design could be modeled as a hemisphere in a semi-infinite tissue (which is the
same as a sphere in an infinite tissue). The designs and their proposed one-dimensional
models are shown in Figure 4.7.
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4.6 Method for Obtaining the Error in Calculated Perfusion due
to 1-D Approximation
4.6.1 Method
It is necessary to determine the errors in calculated perfusion that result from
approximating the 2-dimensional designs as one-dimensional models. Steady-state finite-
difference models (FDM) of both designs were created for this purpose.
Figure 4.8 shows diagrams of the information flow involved in thermodiffusion.
According to the traditional thermodiffusion method (Figure 4.8a), a probe is placed on
perfused tissue (perfusion level unknown) and heated to, and controlled at, a
predetermined temperature, ATb. The power q' required to maintain AT is recorded.
Subsequently, ATb and q' are inserted into an analytical or numerical model of the
probe, from which perfusion is calculated. This calculated perfusion is denoted by walc,
and it is understood that this calculated perfusion differs from the true tissue perfusion,
Wtrue, by an error, Werror.
It is equally feasible (Figure 4.8b) to heat the thermodiffusion probe at a
predetermined rate q" and record the steady-state temperature increment of the probe,
ATb. ATb and q"' are then inserted into an analytical or numerical model of the probe
from which perfusion, walc, is calculated.
In order to analytically determine the error in calculated perfusion resulting from
the approximation of two-dimensional probes by one-dimensional models, the following
procedure was applied (see Figure 4.8c). As in Figure 4.8b, the thermodiffusion probe is
heated at a predetermined rate q', but now the perfusion level in the tissue of the FDM,
Wtrue, is also an input. The steady-state temperature ATb of the probe is obtained from the
iterations of the FDM, and ATb and q"' are inserted into the one-dimensional model, from
which perfusion, wcalc, is calculated as before. The error between calculated perfusion and
true perfusion, Werror, can then be determined as
error true ~ calc
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4.6.1.1 Extra Degree of Freedom for the Spherical Approximation
Approximating the Disk design as a sphere adds an extra degree of freedom, as
shown in Figure 4.9. The radius, a, and height, h, of the probe can be specified, but the
choice of the radius of the spherical model, a*, is not clear. Some possibilities include
choosing:
1. a*=a
2. a* such that the total amount of heat exiting the disk and sphere are equal. Then
a* = -a 2h .(2
3. a* such that the heat fluxes exiting the disk and sphere are equal. Then
a*= 3h.
4. a* such that Wcal=O when wtrueO=. In the laboratory this would involve a simple
no-flow calibration in a high-viscosity liquid (such as glycerol), which is common
practice for invasive probes.
It is not clear by which criterion a* should be determined.
4.6.2 Finite-Difference Model
4.6.2.1 Setup
Finite-difference models (FDM) of the probe and tissue were created for both
designs. As shown in Figure 4.10, symmetry allowed the FDM to be limited to half of the
probe-tissue system in order to save computing power. Since both designs are disk-
shaped, the FDMs were created in cylindrical coordinates. The exposed surfaces and the
symmetry line of the probe and tissue were modeled as being insulated. The boundary
condition for the lower boundary of the tissue was stated in Section 4.1.3 as T-+T
approaching the boundary at infinity. In the FDM this lower bound was implemented by
specifying T,=T, on a semi-hemisphere of "very large radius", R. The error associated
with approximating infinity by R is discussed in Section 4.6.2.2. Tissue perfusion was
implemented in the FDM as stated in the bioheat equation, i.e. as a heat sink. Appendix A
presents the FDM layout and equations for both designs. For a more formal discussion of
FDM and finite-element analysis for tissue, see [46].
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The FDMs were created in Microsoft Excel and solved using Excel's built-in
iteration solver. The advantage of using Excel is two-fold: simple models with few nodes
can be set up and solved very quickly, and Excel's cells can be used as FDM cells,
providing a very helpful graphical representation of the model. The main disadvantage of
Excel is that the number of cells in the horizontal direction (i.e. columns in Excel) is
limited to 256. Thus R is severely limited. In addition, computation time quickly becomes
very large in Excel: when the maximum width of the spreadsheet is used (R=256 cells),
the tissue and probe contain on the order of 50'000 cells, which can take up to 60'000
iterations to solve (up to 6 or 8 hours on a 2 GHz processor).
Since walc is extremely sensitive to ATb (see Section 4.3), it is important to
understand that the value of ATb determined by the FDM is not exactly equal to the true
value of ATb, but differs by an error from three sources:
1. the discretization inherent in finite-difference modeling assumes each cell to have
uniform temperature
2. the iterative solution method ends when the desired level of accuracy is reached,
not when the exact solution is found
3. the boundary at infinity is approximated by a boundary at a very large distance, R
The error between ATb calculated in the FDM and the true temperature increment of the
probe is therefore reduced by:
1. refining the mesh
2. increasing the number of iterations
3. increasing R
A quantitative measure of these approximation errors was obtained by varying each of
these three parameters in turn and observing the resulting change in walc.
4.6.2.2 Validation
Since no exact solutions exist for the proposed designs, it is necessary to validate
the FDM against existing exact solutions for situations that are as similar as possible.
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Unperfused Tissue
In order to validate the implementation in cylindrical coordinates of the FDM, the
tissue temperature profile obtained from the FDM of a semi-infinite, unperfused tissue
heated with uniform flux over a circular region on its surface was compared to Carslaw
and Jaeger's exact solution [45].
Figure 4.11 shows the tissue temperature profiles obtained from the exact solution
and from the FDM. It is seen that the FDM tracks the exact solution very nicely except
for an offset. This offset is due to the fact that the lower tissue boundary was not actually
placed at infinity, but at R. Tm is therefore constrained to equal T at R, pulling the entire
curve down. Appendix B shows that the error in walc caused by this finite value of R is
on the order of 3 kg/m 3 s. The effect of this error is discussed in the subsection
Approximation Error below.
Perfused Tissue
In order to validate the implementation of perfusion, a FDM in spherical
coordinates of a sphere in perfused tissue was created. According to the method outlined
in 4.6.1, walc was obtained and compared to Wtrue. Figure 4.12 shows that the calculated
perfusion tracks true perfusion very nicely.
Approximation Error
More quantitatively, the errors in calculated perfusion resulting from the three
sources of FDM error-discretization, finite number of iterations, and finite R, as
explained above-were estimated by varying each of the sources in turn and observing
the resulting change in Werror. Roughly,
1. refining the probe mesh from 1000 to 2000 cells produced a change in calculated
perfusion on the order of 0.02 kg/m3 s.
2. decreasing the 'maximum change between iterations required to terminate the
iterations' from 10-7 to 10-8 (i.e. increasing the number of iterations) produced a
change in calculated perfusion on the order of 0.06 kg/m3 s.
3. increasing R from 12.7mm to 21.3mm produced a change in calculated perfusion
on the order of 3 kg/m3 s (see Appendix B).
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This analysis demonstrates that the mesh size and number of iterations are
adequate, but that the finite value of R produces a large error (3 kg/m3 s is approximately
equal to the typical level of perfusion in skin and other tissues). As explained above, the
FDM was solved in Microsoft Excel which sets a limit on R. The results are meaningful
despite this large FDM error because the magnitude of werror caused by approximating
two-dimensional probes as one-dimensional (which is the purpose for creating the FDM
in the first place) is huge compared to the FDM error for the infinite slab, and on the
order of the FDM error for the sphere. However, further, more detailed studies definitely
call for FDM in software that can allow for larger R and less computation time.
4.7 Temperature Distributions
4.7.1 Probe and Tissue Temperature Profiles
The output of the finite-difference models (FDM) is the two-dimensional
temperature profile of the probe and adjoining tissue. A number of isotherm plots for the
probe and tissue are shown in Appendix C for the Disk design and the Disk and Ring
design at various levels of perfusion. It can be seen on those plots that increasing
perfusion has the effect of lowering the temperature in the probe as well as tightening the
temperature profile of the tissue closer to the probe (which is the same as decreasing the
interrogated tissue volume).
4.7.2 Volume-averaged Temperature Increment of the Probe, ATb
In practice, the directly measurable probe quantities are voltage, current, and
resistance. The resistance measured represents the thermistor resistance averaged over its
volume. From this measured, volume-averaged resistance and the probe's resistance-vs.-
temperature calibration curve, the volume-averaged temperature of the probe, A Tb, can be
obtained.
Figure 4.13 shows AZTb vs. w for disks of radius a=lmm (q' =7.5MW/m 3) and
a=0.5mm (q'=I0MW/m3). It doesn't make any sense to compare the magnitudes of the
two curves because they are proportional to q' . However, it can be seen that the
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sensitivity of w on ATb is larger for larger radii. This phenomenon is discussed in more
detail in Section 4.3.
Figure 4.14 shows ATb vs. w for the Disk and Ring design of outer radius
a0 ,=2mm for two values of aj, (0.4mm and 0.8mm). It is surprising that the relatively
large reduction in the deviation, 5, caused by increasing a,, 1/aj, from 2.5 to 5 has a very
small effect on AzTb and, as is shown in 4.8.2, on Wcale.
4.8 Results: Error in Calculated Perfusion due to 1-D
Approximation
4.8.1 Disk Design
As discussed in more detail in Section 4.6.1.1, approximating the Disk design as a
sphere adds an extra degree of freedom (see Figure 4.9). The radius, a, and height, h, of
the probe can be specified, but the choice of the radius of the spherical model, a*, is not
clear. Some possibilities include choosing:
1. a*=a.
2. a* such that the total amounts of heat exiting the disk and sphere are equal.
3. a* such that the heat fluxes exiting the disk and sphere are equal.
4. a* such that Wcale=O when wrue=0.
Table 4.1 shows Wcale vs. Wrue for a disk of radius a=lmm, where Wcalc is calculated with
a* determined by each of the four criteria above. Table 4.2 is analogous to Table 4.1 for a
disk of radius a=0.5mm. The fifth column shows wcalc when the thermistor probe is
modeled as an infinite slab, and the last column gives ATb.
It is evident from the tables that IWerror=1Wtrue-Wcalc is extremely large for several
values of a*, meaning that wcalc is extremely sensitive to a*, as discussed in Section 4.3.
It is also evident that even the smallest values of Werror are still very significant over the
physiological range of Wru, from 0 to 15 kg/m3 s.
Also, the best criterion for a disk of radius 1mm in some cases does not work for a
disk of radius 0.5mm. In other words, it is not clear by which criterion a* should be
determined. It is important to realize that no choice of a* will cause Wcalc=W'rue for all
values of Wtrue. There may be a more sophisticated way to match Wcalc and Wtrue, but the
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purpose of this research is to determine whether one can "get away with" simply
approximating the two-dimensional probe design by a one-dimensional model.
The left plot in Figure 4.15 shows the best matches of wcaic vs. Wirue for a-lmm
and a* determined by criteria 3 and 4 above. The graph also shows wcalc for the infinite
slab model. It makes sense that Wcalc for the infinite slab would be much larger than Wirue:
heat escaping the disk-shaped thermistor probe flows downward and sideward, while heat
escaping from an infinite slab flows only downward. The power required to maintain ATb
is therefore larger for the disk than for the slab. When the slab is used as a model of the
disk, the high power input for the same ATb can only be explained by a higher level of
perfusion.
The right plot in Figure 4.15 is analogous to left one, but for a probe radius of
0.5mm. The best matches Of Wcalc vS. wirue are for criteria 1 and 4. The values Of Wcalc for
the infinite slab are not shown because they are in the 700-800 kg/m3 s range.
4.8.2 Disk and Ring
The slab model of the Disk and Ring design does not offer the same degree-of-
freedom phenomenon exhibited by the spherical model of the Disk design. However,
there are more choices in dimensions, as discussed in 4.5.2.2.
Figure 4.16 shows Wcalc vs. Wtrue for aou,=2mm and a aou/ai, ratio of 2.5 and 5. It is
surprising that increasing aou,/ajn from 2.5 to 5, which drastically decreases the adiabat
deviation 3, has negligible effect on Wcalc.
When the Disk design modeled as an infinite slab (see circle markers in the left
plot of Figure 4.15) is compared to the Disk and Ring design modeled as an infinite slab
(both square and triangle markers in Figure 4.16), it is evident that the ring does provide
substantial improvement, as was the idea, decreasing Werror from approximately 200
kg/m 3 s for the Disk design to 40 kg/m 3s for the Disk and Ring design. Also, notice the
fairly linear relationship between Wcalc and Wtrue, at least at higher values of wtrue.
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4.9 Discussion
The feasibility of thermally modeling two probe designs by various one-
dimensional analytical models has been studied. In general, the errors between true
perfusion and calculated perfusion are very large. However, for the Disk design and
hemispherical model, it is possible to reduce the error to a clinically acceptable level by
proper choice of probe and model dimensions. For example, for a disk radius a=mm,
height h=0.2mm, and power q"' = 7.5MW/m 3, and a model radius a* based on criterion 4,
the average error over a physiologic perfusion range of 0 to 15 kg/m3s is approximately
20%. It may be possible to determine an optimal combination of probe dimensions, i.e.
the combination that produces the smallest error.
In some cases where the error in calculated perfusion is prohibitively large, such
as the Disk and Ring design with the slab model, relative measurements are possible
thanks to a fairly linear relationship between Wcalc and wrue.
In terms of manufacturability and cost, the Disk design, being simpler than the
Disk and Ring design, is clearly easier and cheaper to fabricate.
4.10 Suggestions for Further Work
A more thorough investigation of design-model combinations is necessary to
explore various design and model dimensions and find an optimal combination. Perhaps a
non-dimensional analysis would be appropriate. Also, there may exist completely
different design-model combinations that result in smaller errors.
The details of the physical probe design must be finalized, paying special
attention to designing a probe with low thermal mass and high thermal communication
for good dynamic tracking and signal stability. Upon developing an exact perfusion
extraction algorithm, prototypes can be fabricated and validated in vitro at zero perfusion
and then in vivo in an animal model.
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Figure 4.1 Temperature profile in a spherical probe and surrounding tissue for various levels of
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a) the thermodiffusion method initially proposed by Bowman et al.
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Figure 4.10 FDM model.
A diagram of the finite-difference model of half of the probe and tissue, with external boundary
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Wtrue Crit. I Crit. 2 Crit. 3 Crit. 4 Heater ATb
NIA 1.000 0.669 0.600 0.593 N/A NIA
0 4729.88 108.40 0.60 0.00 182.72 3.32 *C
2.5 3997.41 155.53 3.63 1.15 198.71 3.22 *C
5 3584.00 200.27 7.83 3.68 211.47 3.14 *C
10 3107.46 286.74 17.88 10.69 231.98 3.04 C
15 2823.35 373.39 29.25 19.22 248.98 2.96 *C
20 2626.40 462.66 41.64 28.79 264.04 2.90 *C
Table 4.1 wac vs. we., for a=lmm.
The 1t column contains the input to the FDM, wtru. The 6th column contains the output of the FDM,
A Tb. Columns 2 through 6 contain wac. Columns 2 through 5 contain we, calculated by the
hemispherical model using various criteria (top row) to calculate a* (2 "d row, in mm). The criteria
are outlined in Section 4.8.1. The 6 th column contains w,.,, calculated by the planar model. Perfusion
values are in kg/m 3 s.
Wtrue Crit. I Crit. 2 Crit. 3 Crit. 4 Heater ATb
N/A 0.500 0.422 0.600 0.472 N/A NIA
0 29.64 64.34 1736.17 0.00 718.04 2.80 *C
2.5 37.98 58.74 1994.58 0.30 749.93 2.76 *C
5 45.25 54.58 2219.02 0.94 775.23 2.73 *C
10 57.32 48.69 2595.07 2.57 813.55 2.70 *C
15 68.16 44.22 2939.27 4.46 845.00 2.67 *C
Table 4.2 Wcaic vs. wte., for a=0.5mm.
The 1st column contains the input to the FDM, wa,,. The 6 th column contains the output of the FDM,
A Tb. Columns 2 through 6 contain Wcac. Columns 2 through 5 contain Wcaic calculated by the
hemispherical model using various criteria (top row) to calculate a* (2 "d row, in mm). The criteria
are outlined in Section 4.8.1. The 6 th column contains Wcaic calculated by the planar model. Perfusion
values are in kg/m3 s.
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5 Conclusion
This thesis explores the feasibility and subsequent design of a non-invasive
thermodiffusion probe. The clinical study evidenced the promise of a non-invasive probe
by showing that the invasive thermodiffusion probe, applied non-invasively, is capable of
tracking perfusion, with clear advantages over other methods. However, using an
invasive probe in a non-invasive manner caused a number of challenges, necessitating the
development of a truly non-invasive probe. Two designs for a non-invasive probe are
presented.
Because perfusion is not actually measured but estimated from measured
quantities by an analytical or numerical model of the probe, the design of the probe must
occur hand-in-hand with the development of the analytical or numerical model. While no
two-dimensional analytical models exist of a finite, heated object placed on a perfused
medium, one-dimensional analytical models have been developed for an infinite, heated
object placed on a perfused medium and for a spherical, heated object in a perfused
medium. It is natural to begin the design process by proposing a design and trying to "get
away with" approximating the design by one of the existing one-dimensional models.
The main theoretical contribution of this thesis is the development and execution
of a technique to determine the error that results from approximating the two proposed
designs as existing one-dimensional analytical models.
It is shown that, in general, the error between true and calculated perfusion caused
by approximating a two-dimensional geometry by a one-dimensional model is
prohibitively large. Nevertheless, by proper choice of model and of probe and model
dimensions, it appears possible to limit the error to a clinically acceptable range.
88
89
6 Bibliography
[1] J. W. Valvano, J. T. Allen, and H. F. Bowman, "The Simultaneous Measurement
of Thermal-Conductivity, Thermal-Diffusivity, and Perfusion in Small Volumes
of Tissue," Journal of Biomechanical Engineering-Transactions of the Asme, vol.
106, pp. 192-197, 1984.
[2] J. W. Valvano, "The Use of Thermal Diffusivity to Quantify Tissue Perfusion."
Ph.D. Thesis, Cambridge, MA: Massachusetts Institute of Technology, 1981.
[3] H. F. Bowman, "Estimation of Tissue Blood Flow," in Heat Transfer in Medicine
and Biology, vol. 1, A. Shitzer and R. C. Eberhart, Eds. New York: Plenum Press,
1985.
[4] J. T. Walsh, "A Noninvasive Thermal Method for the Quantification of Tissue
Perfusion." M.S. Thesis, Cambridge, MA: Massachusetts Institute of Technology,
1984.
[5] J. G. Webster, "Medical Instrumentation, Application and Design," 3 ed. New
York City, NY: John Wiley & Sons, 1998.
[6] H. F. Bowman, T. A. Balasubramaniam, and M. Woods, "Determination of Tissue
Perfusion from "in vivo" Thermal Conductivity Measurements," Heat Transfer in
Biotechnology - ASME, 1977.
[7] T. A. Balasubramaniam and H. F. Bowman, "Thermal Conductivity and Thermal
Diffusivity of Biomaterials: A Simultaneous Measurement Technique," Journal of
Biomechanical Engineering, vol. 99, pp. 148-154, 1977.
[8] J. C. Chato, "A Method for the Measurement of Thermal Properties of Biologic
Materials," presented at Thermal Problems in Biotechnology, ASME, LCN068-
58741, NY, 1968.
[9] T. A. Balasubramaniam and H. F. Bowman, "Temperature Field Due to a Time-
Dependent Heat Source of Spherical Geometry in an Infinite Medium," Journal of
Heat Transfer-Transactions of the Asme, vol. 96, pp. 296-299, 1974.
[10] T. A. Balasubramaniam, "Thermal Conductivity and Thermal Diffusivity of
Biomaterials: A Simultaneous Measurement Technique." Ph.D. Thesis, Boston,
MA: Northeastern University, 1975.
[11] H. H. Pennes, "Analysis of Tissue and Arterial Blood Temperature in the Resting
Human Forearm," Journal ofApplied Physiology, vol. 1, pp. 93-122, 1948.
[12] R. K. Jain, "Transient Temperature Distributions in an Infinite, Perfused Medium
Due to a Time-Dependent, Spherical Heat-Source," Journal of Biomechanical
Engineering-Transactions of the Asme, vol. 101, pp. 82-86, 1979.
[13] G. T. Martin and H. F. Bowman, "Validation of real-time continuous perfusion
measurement," Medical & Biological Engineering & Computing, vol. 38, pp. 319-
325, 2000.
[14] A. T. Patera, G. Eden, B. B. Mikic, and H. F. Bowman, "Prediction of Tissue
Perfusion from Measurement of Phase Shift between Heat Flux and
Temperature," presented at Winter Annual Meeting, ASME, # 79-WA/HT-7 1,
1979.
[15] Hemedex Inc., "Product Info," [online] www.hemedex.com (accessed 2004),
2002.
90
[16] P. Vajkoczy, H. Roth, P. Horn, T. Lucke, C. Thome, U. Hubner, G. T. Martin, C.
Zappletal, E. Klar, L. Schilling, and P. Schmiedek, "Continuous monitoring of
regional cerebral blood flow: experimental and clinical validation of a novel
thermal diffusion microprobe," Journal ofNeurosurgery, vol. 93, pp. 265-274,
2000.
[17] E. Klar, T. Kraus, J. Bleyl, W. H. Newman, H. F. Bowman, W. J. Hofmann, R.
Von Kummer, M. Bredt, and C. Herfarth, "Thermodiffusion for continuous
quantification of hepatic microcirculation - Validation and potential in liver
transplantation," Microvascular Research, vol. 58, pp. 156-166, 1999.
[18] J. W. Valvano, J. T. Allen, J. T. Walsh, D. J. Hnatowich, J. F. Tomera, H.
Brunengraber, and H. F. Bowman, "An Isolated Rat-Liver Model for the
Evaluation of Thermal Techniques to Quantify Perfusion," Journal of
Biomechanical Engineering-Transactions of the Asme, vol. 106, pp. 187-191,
1984.
[19] K. S. Szaijda, "A digitally controlled analog subsystem for perfusion
measurement." B.S. Thesis, Cambridge, MA: Massachusetts Institute of
Technology, 1987.
[20] K. S. Szaijda, "A digitally data acquisition system for temperature and perfusion
measurement." M.S. Thesis, Cambridge, MA: Massachusetts Institute of
Technology, 1989.
[21] H. F. Bowman, "The bio-heat transfer equation and discriminiation of thermally
significant vessels," Annals of the New York Academy of Sciences, vol. 335, pp.
155-160, 1980.
[22] Department of Independent Study, "Cardiovascular Health," in Life Style
Management Health Education/Physical Education 129. Provo, UT: Division of
Continuing Education, Brigham Young University, 1998, pp. 13-15.
[23] E. C. Klatt, "Cardiovascular Pathology Index," in Organ System Pathology Index,
The Internet Pathology Laboratory for Medical Education, Florida State
University College of Medicine, [online]
http://medlib.med.utah.edu/WebPath/CVHTML/CV004.html and
http://medlib.med.utah.edu/WebPath/CVHTML/CV005.html (accessed 2003),
1994.
[24] F. J. Schoen, "Blood Vessels," in Pathologic Basis of Disease, R. S. Cotran, Ed.,
6 ed. Philadelphia, PA: Saunders, 1999.
[25] T. J. Anderson, "Assessment and treatment of endothelial dysfunction in
humans," Journal of the American College of Cardiology, vol. 34, pp. 631-638,
1999.
[26] T. J. Anderson, A. Uehata, M. D. Gerhard, I. T. Meredith, S. Knab, D.
Delagrange, E. H. Lieberman, P. Ganz, M. A. Creager, A. C. Yeung, and A. P.
Selwyn, "Close Relation of Endothelial Function in the Human Coronary and
Peripheral Circulations," Journal of the American College of Cardiology, vol. 26,
pp. 1235-1241, 1995.
[27] G. T. Martin, personal communication with author, 2001.
[28] H. F. Bowman, personal communication with author, 2003.
[29] J. A. Vita and J. F. Keaney, "Endothelial function - A barometer for
cardiovascular risk?," Circulation, vol. 106, pp. 640-642, 2002.
91
[30] A. K. Andreassen, L. Gullestad, T. Holm, S. Simonsen, and K. Kvernebo,
"Endothelium-dependent vasodilation of the skin microcirculation in heart
transplant recipients," Clinical Transplantation, vol. 12, pp. 324-332, 1998.
[31] R. M. Berne and M. N. Levy, "Principles of Physiology," 3 ed. St. Louis, MO:
Mosby Inc., 2000.
[32] H. D. Kvernmo, A. Stefanovska, K. A. Kirlteboen, and K. Kvernebo,
"Oscillations in the human cutaneous blood perfusion signal modified by
endothelium-dependent and endothelium-independent vasodilators,"
Microvascular Research, vol. 57, pp. 298-309, 1999.
[33] M. C. Corretti, T. J. Anderson, E. J. Benjamin, D. Celermajer, F. Charbonneau,
M. A. Creager, J. Deanfield, H. Drexler, M. Gerhard-Herman, D. Herrington, P.
Vallance, J. Vita, and R. Vogel, "Guidelines for the ultrasound assessment of
endothelial-dependent flow-mediated vasodilation of the brachial artery - A report
of the International Brachial Artery Reactivity Task Force," Journal of the
American College of Cardiology, vol. 39, pp. 257-265, 2002.
[34] A. Shitzer and R. C. Eberhart, "Heat Transfer in Medicine and Biology." New
York: Plenum Press, 1985.
[35] M. Sapoff and R. M. Oppenheim, "Theory and Application of Self-heated
Thermistors," IEEE Proceedings, vol. 51, pp. 1292-1305, 1963.
[36] M. M. Chen, "The Tissue Energy Balance Equation," in Heat Transfer in
Medicine and Biology, A. Shitzer and R. C. Eberhart, Eds. New York: Plenum
Press, 1985.
[37] B. D. Fornage and J. L. Deshayes, "Ultrasound of Normal Skin," Journal of
Clinical Ultrasound, vol. 14, pp. 619-622, 1986.
[38] G. T. Overney, "Human Histology for Amateur Histologists," Microscopy-UK,
[online] www.microscopy-uk.org.uk/mag/artaug02/gohisto.html (accessed 2004),
1995.
[39] S. Singh and R. Swerlick, "Dermal Blood Vessels," in For Health Care
Professionals, American Academy of Dermatology, [online]
www.aad.org/education/dermbloodvessels.htm (accessed 2004), 2003.
[40] C. Livingstone, "Skin," in Gray's Anatomy, 38 ed. Great Britain: Pearson
Professional Limited, 1995.
[41] A. Shitzer and R. C. Eberhart, "Heat Generation, Storage, and Transport
Processes," in Heat Transfer in Medicine and Biology, A. Shitzer and R. C.
Eberhart, Eds. New York: Plenum Press, 1985.
[42] A. T. Patera, "The Effect of Cylindrical Probe Geometry on the Accuracy of
Tissue Perfusion Measurements made with a Thermal Diffusion Probe," B.S.
Thesis, Cambridge, MA: Massachusetts Institute of Technology, 1978.
[43] B. B. Mikic, personal communication with author, 2003-2004.
[44] G. T. Martin, personal communication with author, 2004.
[45] H. S. Carslaw and J. C. Jaeger, Conduction of Heat in Solids, 2 ed. New York:
Oxford University Press, 1946.
[46] A. Shitzer, L. J. Hayes, R. W. Olsen, and R. C. Eberhart, "Finite-difference and
Finite-element Methods of Solution," in Heat Transfer in Medicine and Biology,
A. Shitzer and R. C. Eberhart, Eds. New York: Plenum Press, 1985.
92
93
7 Appendix A: Finite-Difference Model
As outlined in Section 4.6.2, I created a finite-difference model (FDM) for the
Disk design and the Disk and Ring design. The FDM for the Disk design is actually just a
degenerate version of the FDM for the Disk and Ring design.
I created the FDM in Microsoft Excel and solved it using Excel's built-in iteration
solver. The advantage of using Excel is two-fold: simple models with few nodes can be
set up and solved very quickly, and Excel's cells can be used as FDM cells, providing a
very helpful graphical representation of the model. The main disadvantage of Excel is
that the number of cells in the horizontal direction (i.e. columns in Excel) is limited to
256. Thus R is severely limited. In addition, computation time quickly becomes very
large in Excel: when the maximum width of the spreadsheet is used (R=256 cells), the
tissue and probe contain on the order of 50'000 cells, which can take up to 60'000
iterations to solve (up to 6 or 8 hours on a 2 GHz processor).
Figure 7.1 shows the entire layout of the FDM, where dots represent temperature
nodes and cells represent areas approximated as having uniform temperature. The layout
is not to scale. Also, only a small number of nodes, in disproportion, are shown for
illustration purposes. As shown, symmetry allowed the FDM to be limited to half of the
probe-tissue system in order to save computing power. Since both designs are disk-
shaped, the FDMs were created in cylindrical coordinates. There is also angular
symmetry about the r=O axis, so the FDM is a two-dimensional model in r and z (see
Figure 7.1). The origin of the z-axis is immaterial. The exposed surfaces and the
symmetry line of the probe and tissue were modeled as being insulated (shown as hatched
lines). The boundary condition for the lower boundary of the tissue was stated in the
Section 4.1.3 as T--Ti approaching the boundary at infinity. In the FDM this lower
bound was implemented by specifying T,=T on a semi-hemisphere of "very large
radius," R. These boundary nodes (for which the temperature is specified as T) are shown
as white dots. The error associated with this approximation, as well as the other
approximations inherent in finite-difference modeling, are presented in Section 4.6.2.
Tissue perfusion was implemented in the FDM as stated in the bioheat equation, i.e. as a
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heat sink. For a more formal discussion of FDM and finite-element analysis for tissue,
see [35].
Because walc is extremely sensitive on measurement errors in A Tb, the probe was
modeled with a finer mesh than the tissue. This was achieved, as shown in Figure 7.1, by
choosing Arb< Arm and Ahb< Ahm, where Ar is the cell width, Ah the cell height, and b and
m refer to probe and tissue, respectively. Implementation in Excel necessitated splitting
the tissue into a coarse-mesh area covering the vast majority of the modeled tissue
volume, and an intermediate-mesh area (Ahm but Arb) located directly below the probe.
These three areas (one for probe and two for tissue) are separated in Figure 7.1 by the
thick line running through nodes 11 and 15, and the thick line running through nodes 15
and 16. Nodes located on the boundaries between these three areas have asymmetric cells
and require special attention.
The thick triple line dividing the probe vertically represents the boundary between
the inner disk and outer ring of the Disk and Ring design. The FDM for the Disk design
can be obtained by simply ignoring this line and treating nodes 5-8, 12, and 13 as node 1.
Following the standard method of formulating finite-difference equations from an
energy balance on a given cell, I developed the equations for the node temperature of
each cell, Tmn. The cells can be divided into groups of nodes having the same node
equation:
* Probe and tissue center-nodes (1, 17, 19)
* Boundary nodes (2-6, 9-10, 18, 20)
* Probe-tissue interface nodes (12-14)
* Probe-tissue interface and boundary nodes (11, 15)
* Nodes on boundary between intermediate- and coarse-mesh tissue areas (16)
* Only for Disk and Ring design: nodes on the interface of inner disk and outer
ring (5-8, 12, 13)
The equations for the temperatures of these nodes are given on the following
pages.
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8 Appendix B: Error due to Finite Extent of FDM
As stated in Section 4.6.2.2, the errors in perfusion calculated from a finite-
difference model are due to three sources: discretization, finite number of iterations, and
finite R (R is the radius of the boundary that approximates infinity). The error due to
finite R deserves more attention. In the governing equation of the temperature distribution
in the tissue, the boundary condition for the lower boundary of the tissue is T--+Ti
approaching the boundary at infinity. In the FDM this lower bound was implemented by
specifying T,=T on a semi-hemisphere of "very large radius", R.
The approximation errors due to these three sources were estimated by varying
each of the sources in turn and observing the change in calculated error. Roughly,
1. refining the probe mesh from 1000 to 2000 cells produced a change in calculated
perfusion on the order of 0.02 kg/m3 s.
2. decreasing the 'maximum change between iterations required to terminate the
iterations' from 10- to 10~8 (i.e. increasing the number of iterations) produced a
change in calculated perfusion on the order of 0.06 kg/m3 s.
3. increasing R from 12.7mm to 21.3mm produced a change in calculated perfusion
on the order of 3 kg/m3s.
This analysis demonstrates that the mesh size and number of iterations are
adequate, but that the finite value of R produces a large error (3 kg/m3 s is often the
typical level of perfusion in skin and other tissues). It is clear that it is not enough to
know the error due to approximating infinity as R=12.7mm instead of R=21.3mm, but
that the error from approximating infinity as R=1 2.7mm instead of infinity must be
known in order to justify the use of the FDM.
I have used the FDM to compute A Tb for three different values of R, plotted in
Figure 8.1 along with a second-order polynomial fit (dotted line). Because only the
differences between A Tb-values at different R-values is important, A T at R=12.7mm is
replaced by zero. Using this polynomial fit, the value of R for which aMTb/aR=0 is
R=21.3Imm. Plugging R=21.31mm back into the polynomial fit, A Tb =42.6ImC (mC =
'C/ 1000) is approximately the error in A Tb associated with approximating infinity by
12.7mm instead of infinity. A plot from the analytical model of w vs. A Tb (around
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A Tb=3"C and with typical probe and tissue thermal properties and a=lmm) shows that a
change in A Tb of 20mC produces a change in w on the order of 1.5kg/m 3 s. Thus, the
error in Wcalc produced by approximating infinity by R=12.7mm is on the order of
3kg/m 3s.
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Figure 8.1 A Tb vs. R (slid line) with second-order polynomial fit (dashed line) and equation.
Correlation=1.
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9 Appendix C: FDM Isotherm Plots of Probe and Tissue
The output of the FDM is a temperature value for each of the 20'000 to 50'000
cells (depending on the mesh size and the value of R). On the following pages are plotted
the isotherms of the probe and tissue at various values of perfusion, but at the same probe
heat input qb'"'. Probe and tissue plots only show the left half of the probe and tissue. In
the plots of the tissue isotherms, the origin marks the center of the probe-tissue interface.
In the plots of the probe isotherms, the origin marks the center of the top surface of the
probe, i.e. the center of the surface not in contact with tissue.
Note that as perfusion increases, more of the heat generated in the probe is carried
away by convection (in addition to the heat carried away by conduction), and therefore
the temperatures in the probe and the tissue decrease. In other words, as perfusion
increases, the heat penetrates less deep into the tissue, which is the same as saying that
the interrogated tissue volume decreases.
9.1 Disk Design
Figures 9.1-9.3 show tissue isotherms and Figure 9.4 shows probe isotherms at
w=0, 5, and 15 kg/m3 s for the Disk design. ATb=3.3171830 C, 3.143704'C, 2.964222'C,
respectively; a=Imm; h=0.2mm; Arb=0.02mm; Ar,=0.Imm; Ahb=0.0Imm; Ah,=O.Imm;
R=12.7mm; maximum change for iteration termination=10-7; qb .'=7.5MW/M3.
Approximately 25,000 cells total. Tissue and probe thermal properties as listed in List of
Values.
9.2 Disk and Ring Design
Figures 9.5-9.7 show tissue isotherms and Figure 9.8 shows probe isotherms at
w=0, 5, and 15 kg/m3 s for the Disk and Ring design. A T=4.5137920 C, 3.868039"C,
3.440828*C, respectively; a1,=0.4mm; a0u,=2mm; h=0.2mm; Arb=0.04mm; Arm=0.2mm;
Ahb=0.02mm; Ah,=0.2mm; R=42mm; maximum change for iteration termination=l0-7;
qb,i "'= qb,out .'=5MW/m3. Approximately 49'000 cells total. Tissue and probe thermal
properties as listed in List of Values.
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Figure 9.1 Disk design: tissue isotherms at w=O (top: far-view, bottom: close-view). Axis dimension:
mm; temperature dimension: "C. T=35"C.
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Figure 9.2 Disk design: tissue isotherms at w=5 kg/m 3s (top: far-view, bottom: close-view). Axis
dimension: mm; temperature dimension: "C. T,=35"C.
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Figure 9.3 Disk design: tissue isotherms at w=15 kg/Ms
dimension: mm; temperature dimension: 'C. T,=35"C.
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Figure 9.4 Disk design: probe isotherms at w=O (top), w=5 kg/m3 s (middle), and w=15 kg/m3 s
(bottom). Axis dimension: mm; temperature dimension: 'C. T,=35"C.
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Figure 9.5 Disk and Ring design: tissue isotherms at w=O (top:
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Figure 9.6 Disk and Ring design: tissue isotherms at w=5 kg/m3 s (top: far-view, bottom: close-view).
Axis dimension: mm; temperature dimension: "C. T1=35"C.
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Figure 9.7 Disk and Ring design: tissue isotherms at w=5 kg/M3s (top: far-view, bottom: close-view).
Axis dimension: mm; temperature dimension: 'C. Ti=35"C.
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Figure 9.8 Disk and Ring design: probe isotherms at w=O (top), w=5 kg/m3s (middle), and w=15
kg/m 3s (bottom). Axis dimension: mm; temperature dimension: "C. T;=35 0C.
